21 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
19
Identification of Novel GPR55 Modulators Using Cell-Impedance-Based Label-Free Technology.

Instituto De Qu£Mica M£Dica
7
Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-ones.

University of North Carolina At Greensboro
4
Indoloditerpenes from a marine-derived fungal strain of Dichotomomyces cejpii with antagonistic activity at GPR18 and cannabinoid receptors.

University of Bonn
45
8-Benzamidochromen-4-one-2-carboxylic acids: potent and selective agonists for the orphan G protein-coupled receptor GPR35.

University of Bonn
67
Antagonists for the orphan G-protein-coupled receptor GPR55 based on a coumarin scaffold.

University of Bonn
8
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.

University of Bonn
42
Emerging targets in osteoporosis disease modification.

Amgen
29
Stereoisomers of cannabidiols and their pharmacological activities - A potentially novel direction for cannabinoids.

University Health Network
25
Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure-Activity Relationship.

IQM-CSIC
7
Phytocannabinoid Pharmacology: Medicinal Properties of

Scientus Pharma
19
Discovery of Tricyclic Xanthines as Agonists of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18.

University of Bonn
5
The Essential Medicinal Chemistry of Cannabidiol (CBD).

University of Minnesota
9
Discovery of 1,4-Naphthoquinones as a New Class of Antiproliferative Agents Targeting GPR55.

University of Calabria
17
Potent and selective N-(4-sulfamoylphenyl)thiourea-based GPR55 agonists.

University of Eastern Finland
34
Structure-activity relationships of imidazothiazinones and analogs as antagonists of the cannabinoid-activated orphan G protein-coupled receptor GPR18.

University of Bonn
24
Design, synthesis and biological evaluation of GPR55 agonists.

University of North Carolina At Greensboro
18
Diaryl macrocycles as modulators of protein kinases

Tp Therapeutics
234
Biaryl kinase inhibitors

Bristol Myers Squibb
130
Compounds useful for treating disorders related to RET

Blueprint Medicines
30
Stereospecific high-affinity TRPV1 antagonists: chiral N-(2-Benzyl-3-pivaloyloxypropyl) 2-[4-(methylsulfonylamino)phenyl]propionamide analogues.

Seoul National University
9
Isoform selective inhibition of STAT1 or STAT3 homo-dimerization via peptidomimetic probes: structural recognition of STAT SH2 domains.

Yale University